MedPath
NMPA Approval

Escitalopram Oxalate Oral Solution

国药准字H20253930

April 15, 2025

Drug Information

草酸艾司西酞普兰口服溶液

口服溶液剂

240ml:240mg(按C₂₀H₂₁FN₂O计)

化学药品

April 15, 2025

Company Information

Applicant Company

苏州工业园区若水路388号纳米技术国家大学科技园D幢7楼

Manufacturing Company

南京市江北新区科创大道18号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

草酸艾司西酞普兰口服溶液 - NMPA 批准文号 | MedPath